Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dsernil Sandoz
2. Dsernil-sandoz
3. Deseril
4. Desril
5. Dimaleate, Methysergide
6. Dimethylergometrin
7. Maleate, Methysergide
8. Methylmethylergonovine
9. Methysergide
10. Methysergide Dimaleate
11. Sansert
12. Uml 491
13. Uml-491
14. Uml491
1. 129-49-7
2. Methysergide Maleate Salt
3. Methysergide Hydrogen Maleate
4. Deseril-retard
5. Desernil Bismaleate
6. Methysergide Maleate [usp]
7. 129-49-7 (maleate)
8. 2u7h1466gh
9. Nsc-759143
10. Methysergide Maleate (usp)
11. Methysergide Bimaleate
12. 1-methyl-d-lysergic Acid Butanolamide Dimaleate
13. Mls000069364
14. (6ar,9r)-n-[(2s)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide; Maleate (1:1)
15. Ergoline-8-carboxamide,9,10-didehydro-n-[(1s)-1-(hydroxymethyl)propyl]-1,6-dimethyl-, (8b)-,(2z)-2-butenedioate (1:1) (salt)
16. Smr000058483
17. Einecs 204-950-9
18. Nsc 186061
19. Unii-2u7h1466gh
20. Sansert (tn)
21. Lysergamide, N-((1-hydroxymethyl)propyl)-1-methyl-, Maleate
22. Methysergidemaleate
23. Regid855989
24. (+)-n-((1-hydroxymethyl)propyl)-1-methyl-d-lysergamide Bimaleate
25. (6ar,9r)-n-[(2s)-1-hydroxybutan-2-yl]-4,7-dimethyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide;(z)-but-2-enedioic Acid
26. 1-(hydroxymethyl)propylamide Of 1-methyl-(+)-lysergic Acid Hydrogen Maleate
27. 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide Maleate (1:1) (salt)
28. Mls001076153
29. Chebi:6894
30. Chembl1200938
31. Methysergide Maleate Salt, Solid
32. Schembl21803661
33. Dtxsid901017106
34. Hms2093n13
35. Hms2231l15
36. Hms3262n07
37. Hms3414j11
38. Hms3678j09
39. Hms3887o05
40. Pharmakon1600-01505492
41. Methysergide Maleate Assay Standard
42. Methysergide Maleate [vandf]
43. Tox21_500863
44. Methysergide Maleate [mart.]
45. Nsc759143
46. Methysergide Maleate [usp-rs]
47. Methysergide Maleate [who-dd]
48. Akos024456362
49. Ccg-213467
50. Lp00863
51. Ncgc00261548-01
52. Ergoline-8-beta-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, Maleate (1:1) (salt)
53. Ergoline-8-carboxamide, 9,10-didehydro-n-((1s)-1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (2z)-2-butenedioate (1:1) (salt)
54. Ergoline-8-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8beta)-, (z)-2-butenedioate (1:1) (salt)
55. Ergoline-8beta-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, Maleate (1:2) (salt)
56. Methysergide Hydrogen Maleate [mi]
57. Methysergide Maleate [orange Book]
58. Smr000653472
59. Methysergide Maleate [usp Impurity]
60. Methysergide Maleate [usp Monograph]
61. Eu-0100863
62. M-137
63. D00681
64. Sr-01000002986
65. Sr-01000002986-2
66. Q27255601
67. Methysergide Maleate, United States Pharmacopeia (usp) Reference Standard
68. [8?(s)]-9,10-didehydro-n-[1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide Maleate
69. 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8.beta.-carboxamide Maleate (1:1) (salt)
70. Ergoline-8-carboxamide, 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethyl-, (8.beta.)-, (z)-2-butenedioate (1:1) (salt)
| Molecular Weight | 469.5 g/mol |
|---|---|
| Molecular Formula | C25H31N3O6 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 6 |
| Exact Mass | 469.22128572 g/mol |
| Monoisotopic Mass | 469.22128572 g/mol |
| Topological Polar Surface Area | 132 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 697 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Methysergide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methysergide, including repackagers and relabelers. The FDA regulates Methysergide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methysergide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Methysergide supplier is an individual or a company that provides Methysergide active pharmaceutical ingredient (API) or Methysergide finished formulations upon request. The Methysergide suppliers may include Methysergide API manufacturers, exporters, distributors and traders.
Methysergide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methysergide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methysergide GMP manufacturer or Methysergide GMP API supplier for your needs.
A Methysergide CoA (Certificate of Analysis) is a formal document that attests to Methysergide's compliance with Methysergide specifications and serves as a tool for batch-level quality control.
Methysergide CoA mostly includes findings from lab analyses of a specific batch. For each Methysergide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methysergide may be tested according to a variety of international standards, such as European Pharmacopoeia (Methysergide EP), Methysergide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methysergide USP).
LOOKING FOR A SUPPLIER?
